alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with Mitochondrial Diseases in 1 studies
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid: An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies.
Mitochondrial Diseases: Diseases caused by abnormal function of the MITOCHONDRIA. They may be caused by mutations, acquired or inherited, in mitochondrial DNA or in nuclear genes that code for mitochondrial components. They may also be the result of acquired mitochondria dysfunction due to adverse effects of drugs, infections, or other environmental causes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strahlendorf, J | 1 |
| Box, C | 1 |
| Attridge, J | 1 |
| Diertien, J | 1 |
| Finckbone, V | 1 |
| Henne, WM | 1 |
| Medina, MS | 1 |
| Miles, R | 1 |
| Oomman, S | 1 |
| Schneider, M | 1 |
| Singh, H | 1 |
| Veliyaparambil, M | 1 |
| Strahlendorf, H | 1 |
1 other study available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Mitochondrial Diseases
| Article | Year |
|---|---|
AMPA-induced dark cell degeneration of cerebellar Purkinje neurons involves activation of caspases and apparent mitochondrial dysfunction.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Animals, Newborn; bcl-2-Associate | 2003 |